A new publication on histrelin was released on October 9, 2026. The case report, titled "Case Report: Sustained pubertal suppression for 68 months with a single histrelin acetate implant in central precocious puberty," appeared in Frontiers in Endocrinology. Histrelin is an approved compound. The publication is listed under PubMed ID 42920604. This entry represents a case report format, meaning it describes a single documented clinical instance rather than a broader trial or study. No additional details beyond the title, journal, and publication date were provided in the event data. Readers interested in the background and general profile of histrelin can consult the compound overview for further context.
Case Report on Histrelin Implant Published in Frontiers in Endocrinology
See the full histrelin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42920604/